Nova News

May
2020

EYRIS SIGNS MOU WITH SINGAPORE OPTOMETRIST ASSOCIATION

Mar 2020 – Many amongst the general population are oblivious to the need for regular eye examination. To underscore this need, most of these eye conditions are silent and asymptomatic during early stages which can be vision threatening when it takes a turn for the worse. As professionals regulated by the Optometrist and Optician Board (OOB), optometrists are trained and…

Read more

Mar
2020

NOVA SECURES NATIONWIDE PROJECT TO IMPLEMENT VESALIUS IN TONGA

Mar 2020 –The Ministry of Health, Kingdom of Tonga awarded VAMED, an international end-to-end provider of solutions to healthcare facilities – the project for management, implementation and support of the nationwide Health Information System (HIS) and Electronic Medical Record (EMR). Tonga has a population of about 107,000 people living on 170 islands spread across 750,000 square kilometers in the southern…

Read more

Mar
2020

SELENA+ OBTAINS APPROVAL FOR MARKET ACCESS IN EU

9 Mar 2020 – EyRIS is pleased to announce that SELENA+, a deep learning AI system designed to detect diabetic retinopathy, glaucoma-suspect and age-related macular degeneration, jointly invented by clinicians and scientists from Singapore Eye Research Institute (SERI) and NUS School of Computing has received CE Marking certification. EyRIS is a start-up company established to commercialise SELENA+, which was trained…

Read more

Jan
2020

EYRIS CO-FOUNDER DISCUSSES THE FUTURE OF AI IN OPHTHALMOLOGY

Jan 2020 – In the article published by the The Ophthalmologist – Ophthalmic Frontiers: AI, four recognized artificial intelligence and deep learning gurus discuss the use of these advanced technologies in eye care – and predict where they may take us next. We are pleased to share that Dr Daniel Ting, an EyRIS co-founder is one of the selected experts…

Read more

Jan
2020

EYRIS CLEARS EN ISO13485:2016 AUDIT

Jan 2020 – EyRIS is pleased to announce that we has successfully undergone Phase 1 & 2 of EN ISO 13485:2016 audit by TÜV SÜD that was conducted across 2 days. The EN version required additional annexes to ensure compliance to quality management system clauses stated in the Medical Device Directive (MDD 93/42/EEC) Annex II. In addition, the product technical…

Read more

Jan
2020

LAND TRANSPORT AUTHORITY, SINGAPORE AWARDS PROJECT TO NOVA FOR ERA SYSTEM UPGRADE

Jan 2020 –Singapore’s Land Transport Authority (LTA) has awarded to novaCITYNETS the project to upgrade and enhance the web-based Enterprise Registry and Archival (ERA) System. The ERA System became operational in March 2014 and since then system has been heavily utilised as the corporate-wide records and document management platform, with an aim to provide end-to-end management for all corporate resources…

Read more

Dec
2019

NOVA RECEIVES GDPMD CERTIFICATION

Dec 2019 – Adaptive artificial intelligence and deep learning technologies such as SELENA+ differ from other software as a medical device (SaMD) in that they have the unique potential to adapt and optimize performance to continuously improve health care for patients. The International Medical Device Regulators Forum (IMDRF) defines software as a medical device as software intended to be used…

Read more

Nov
2019

NATIONAL AI STRATEGY: THE NEXT KEY FRONTIER OF SINGAPORE’S SMART NATION JOURNEY

Nov 2019 – Singapore’s National Artificial Intelligence (AI) Strategy is a key step in their Smart Nation journey. It spells out the plans to deepen use of AI technologies to transform the economy, going beyond just adopting technology, to fundamentally rethinking business models and making deep changes to reap productivity gains and create new areas of growth. One of the…

Read more

Nov
2019

SELENA+ MENTIONED BY DPM HENG IN ANNOUNCEMENT OF NATIONAL ARTIFICIAL STRATEGY

13 Nov 2019 – At the Singapore FinTech Festival (SFF) x the Singapore Week of Innovation and TeCHnology (SWITCH) Conference, Singapore’s Deputy Prime Minister Mr Heng Swee Keat unveiled the “National AI Strategy” which maps out the deployment of AI to improve lives of citizens. The key approach of the national strategy is to adopt a human-centric approach and focus…

Read more

Oct
2019

REGULATORY BODY APPROVES MARKETING OF SELENA+ THAT CAN DETECT 3 EYE DISEASES

Oct 2019 – It is with great pleasure to announce EyRIS’s first medical device after Heath Science Authority of Singapore (HSA) gave us the official approval. Our medical device, SELENA+, is an effective assistive tool in the diagnosis of 3 eye diseases, diabetic retinopathy (DR), Glaucoma and Age-Related Macular Degeneration (AMD). This approval closely follows the ISO13485:2016 certification we received…

Read more